Your browser is old and is not supported. Upgrade for better security.

Invest in Biomedican

Producing the highest quality and lowest cost cannabinoids via biosynthesis

Pitch Video
Investor Panel

Highlights

1
4 patents pending producing the best results in the market. Less than $1 a gram production costs per cannabinoid.
2
Producing 99% pharmaceutical grade, Bioorganic, Non-GMO, 70-90% less than current wholesale prices
3
Successfully biosynthesized CBG/CBGA, THCV/THCVA and CBN/CBNA. Sustainably using 90% less resources
4
CGA benefits: reduces pain, inflammation; helps treat Inflammatory Bowel disease IDB, Glaucoma, Huntington's disease
5
THCV benefits: appetite suppressant, helps with diabetes, reduces inflammation, neuroprotectant, supports bone growth
6
Over 70 articles published on the company in Forbes, Bloomberg, Nasdaq, Reuters, Maxim, Rolling Stones
7
Research partnerships: Institute of Genetics Moscow, Demark Technical University, Imperial College UK
8
One of the fastest growing markets in the world expected to reach 25 mil in 2025

Our Team

We believe that biosynthesis will shape the future and significantly influence the production of food, supplements, medical drugs, and other valuable organic compounds. We have identified rare cannabinoids as the starting point due to the high demand and limited availability. However, this is just the beginning, and we

Pitch

Overview